Review guidelines and key data on modifying ART in virologically suppressed patients, including switching ART to decrease pill burden and avoid comorbidities, switching to a long-acting injectable, and simplifying ART in the context of known multidrug resistance.
In this episode, David Malebranche, MD, MPH, discusses modifying ART in virologically suppressed patients, including switching ART in a patient with daily pill fatigue, switching ART to avoid comorbidities and simplifying ART in the context of known multidrug resistance. The overview will include analyses from:
In addition, Dr. Malebranche reviews current recommendations by the DHHS regarding considerations when switching regimens in virologically suppressed patients and switching regimens in patients with viral suppression and drug resistance.
Presenter:
David J. Malebranche, MD, MPH
Internal Medicine Physician
HIV/Sexual Health Specialist
Clinician, AIDS Healthcare Foundation (AHF) Medical Clinic
Atlanta, Georgia
Follow along with the slides at:
https://bit.ly/3kseOqk
Content based on an online CME program supported by an educational grant from ViiV Healthcare.
Link to full program:
https://bit.ly/3ux6FF8